Insulin-creating cell research can lead to better diabetes treatment

Tagged: , , , , , , ,

Insulin-creating cell research can lead to better diabetes treatment

Published on October 29, 2010 with No Comments

Beta cells, which make insulin in the body, do not replicate after age 30, indicating that clinicians might be closer to better treating diabetes. Your body is the result of a lack of beta cells by auto-immunity while type 2 is due to a relative insufficiency of beta cells. Whether beta cells replicate after birth has always been a wide open issue, and it is crucial for designing therapies for diabetes.

By using radioactive carbon-14 made by above-ground nuclear testing within the 1950s and ’60s, scientific study has determined that the amount of beta cells remains static after age 30.

Lawrence Livermore National Laboratory scientist Bruce Buchholz, with collaborators from the National Institutes of Health, used two methods to examine adult human beta cell turnover and longevity.

Using LLNL’s Center for Accelerator Mass Spectrometry, Buchholz measured the quantity of carbon 14 in DNA in beta cells and discovered that after age 30, your body doesn’t create any new beta cells, thus decreasing the capability to create insulin like a person ages.

Carbon 14 atmospheric concentration levels remained relatively stable before Cold War, when above-ground nuclear bomb tests caused a clear, crisp increase, or peak, which decreased slowly after the end of above-ground testing in 1963. This spike in carbon 14 within the atmosphere serves as a chronometer of history 57 years.

Because DNA is stable following a cell went through its last cell division, the concentration of carbon 14 in DNA can serve as to start dating ? mark for when a cell was created and may be used to date cells in humans

“We found that beta cells turnover as much as about age 30 there they remain throughout life,” Buchholz said. “The findings have implications for both type 1 and diabetes type 2.”

Your body is an auto-immune disease where the body attacks beta cells. Both genetic predisposition and environmental triggers that are poorly understood have been implicated within the disease development. Disease onset is frequent during childhood but could occur throughout life as well as lifelong insulin injections/pump delivery. Your body simply lacks the ability to make insulin. Type 2 diabetes (often called adult onset diabetes) is common in older people whose capability to secrete sufficient insulin to manage blood sugar levels deteriorates because they age and is often because of increased demand in obese people.

“It could be because of lack of beta cells with age,” Buchholz said. “The body doesn’t make new ones in adulthood there is probably not enough cells to control blood sugar levels.”

Additionally, as the obesity rate increases, the incidence of diabetes type 2 increases which is now getting to be found in obese children.

Buchholz said there is active research in stem cell therapies to replace lost beta cells for both types of diabetes. “But with these new findings, it’s not clear how easy it will likely be to find the body to make more beta cells in adulthood, when it is not really a natural process,” he explained. “At the surface, it appears as though coaxing your body to complete what it really does naturally will be simpler to accomplish.”

DOE/Lawrence Livermore National Laboratory